GCH1 and colorectal carcinoma: To be more specific, blocking GCH1/BH4 promotes ferroptosis induced by Erastin via ferritinophagy, suggesting that GCH1 inhibitors combined with Erastin are probably a novel therapeutic strategy for CRC [74].